|Podcasts|August 23, 2022
SMO, A Model Sustained By Necessity
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Ian Smith MBE MB ChB.B MedSc(Hons), Founder, Director and Chief Medical Officer of Panthera Biopartners, and Chris Dodd, the company's Chief Commercial Officer, discuss the evolution of the Site Management Organization and Panthera Biopartners, how clinical trials remain mired in underperformance and difficulties, and hybrid trial advancements.
Related Content
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
3
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
4
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
5